Maura L Gillison - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maura L Gillison

Showing results (71-80 of 153) with videos related to

Pageof 16

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell CarcinomasFaye M Johnson, Madison P O'Hara, Lacin Yapindi, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 3, 2011

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adultsDaniel C Beachler, Kathleen M Weber, Joseph B Margolick, et al.

Head & Neck|April 4, 2017

Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirusEric D Miller, Dukagjin M Blakaj, Benjamin J Swanson, et al.

Genome Research|November 9, 2013

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityKeiko Akagi, Jingfeng Li, Tatevik R Broutian, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2025

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr-Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic StudiesA Dimitrios Colevas, Zahra Talebi, Elizabeth Winters, et al.

Sexually Transmitted Diseases|January 14, 2015

A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionDaniel C Beachler, Raphael Viscidi, Elizabeth A Sugar, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaChristine H Chung, Qiang Zhang, Christina S Kong, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2006

Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient careMalcolm V Brock, Craig M Hooker, Eric A Engels, et al.

American Journal of Epidemiology|December 7, 2014

Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adultsDaniel C Beachler, Elizabeth A Sugar, Joseph B Margolick, et al.

Iscience|July 3, 2024

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profilesShan He, Matthew M Gubin, Hind Rafei, et al.

Pageof 16

Search research articles

Showing results (71-80 of 153) with videos related to

Sort By:

Pageof 16

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2024

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell CarcinomasFaye M Johnson, Madison P O'Hara, Lacin Yapindi, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 3, 2011

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adultsDaniel C Beachler, Kathleen M Weber, Joseph B Margolick, et al.

Head & Neck|April 4, 2017

Sinonasal adenoid cystic carcinoma: Treatment outcomes and association with human papillomavirusEric D Miller, Dukagjin M Blakaj, Benjamin J Swanson, et al.

Genome Research|November 9, 2013

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityKeiko Akagi, Jingfeng Li, Tatevik R Broutian, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2025

Sexually Transmitted Diseases|January 14, 2015

A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infectionDaniel C Beachler, Raphael Viscidi, Elizabeth A Sugar, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaChristine H Chung, Qiang Zhang, Christina S Kong, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2006

Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient careMalcolm V Brock, Craig M Hooker, Eric A Engels, et al.